Long-Term Assets: The sum of all assets classified as non-current.
Cidara Therapeutics, Inc. (CDTX) had Long-Term Assets of $2.54M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-25.72M |
|
-- |
|
-- |
|
$27.38M |
|
$-27.38M |
|
$1.67M |
|
$-25.72M |
|
$-25.72M |
|
$-25.72M |
|
$-25.72M |
|
$-25.72M |
|
$-25.72M |
|
$-27.38M |
|
$-27.36M |
|
15.55M |
|
15.55M |
|
$-1.65 |
|
$-1.65 |
|
| Balance Sheet Financials | |
$531.79M |
|
$0.32M |
|
|
Long-Term Assets |
$2.54M |
$534.33M |
|
$32.32M |
|
-- |
|
$0.84M |
|
$33.15M |
|
$501.17M |
|
$501.17M |
|
$501.17M |
|
23.23M |
|
| Cash Flow Statement Financials | |
$-62.91M |
|
$0.18M |
|
$383.46M |
|
$196.18M |
|
$516.91M |
|
$320.74M |
|
$4.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-62.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.13% |
|
-5.13% |
|
-4.81% |
|
-5.13% |
|
$21.57 |
|
$-4.03 |
|
$-4.05 |
|